Effects of RIF@PLA‐PEG‐Gd/Mal‐RVG29 on the improvement of cognitive function, Aβ deposition, synaptic ultrastructure, a synaptic protein, and changes in neuron morphology in APP/PS1 mice with AD were further explored. Here, APP is linked to Alzheimer disease.